Gianluca Roma
Company: EV Therapeutics
Job title: CEO
Bio:
Gianluca Roma is the CEO and co-founder of EV Therapeutics, a pre-clinical company developing extracellular vesicle-based therapeutic cancer vaccines to help patients qualify for checkpoint inhibitor therapy in gastrointestinal cancers. Gianluca began his career at Gen-Probe where he developed several FDA-approved clinical diagnostic tests. Upon completing an MBA, he transitioned into product management and worked at several large biotechnology companies. He went on to co-found InKaryo Corporation, a next-generation sequencing start-up and led the business to its acquisition by Esperite. Later, Roma joined Applied StemCell and led their newly-formed AccuRef Diagnostics business to acquisition by Abcam.
Seminars:
Chair’s Opening Remarks 8:50 am
day: Pre-Conference Focus Day
Panel Discussion: Harnessing Novel Technologies to Effectively Measure, Isolate & Characterise Exosome Cargoes 12:00 pm
What novel technologies are coming onto the market to facilitate exosome characterization and advance the development of future therapeutics? What are the current challenges of isolating, purifying, and measuring exosomes effectively? How to effectively leverage novel imaging tools to successfully analyze exosome morphology and modifications?Read more
day: Pre-Conference Focus Day